(Press-News.org) Immune cells may be responsible for drug resistance in melanoma patients, according to research published in Cancer Discovery.
Cancer Research UK scientists at The University of Manchester found that chemical signals produced by a type of immune cell, called macrophages, also act as a survival signal for melanoma cells.
When the researchers blocked the macrophages' ability to make this signal - called TNF alpha - melanoma tumours were much smaller and easier to treat.
When melanoma patients are given chemotherapy or radiotherapy it causes inflammation, increasing the number of macrophages in the body – and raising the levels of TNF alpha. This research suggests that targeting this chemical 'survival signal' could lead to new ways to treat the disease.
Dr Claudia Wellbrock, study author and Cancer Research UK scientist at The University of Manchester and member of the Manchester Cancer Research Centre, said: "This discovery shows that immune cells can actually help melanoma cells to survive. Particularly when patients are receiving treatment, the immune cells produce more of the survival signal, which makes treatment less effective. So combining standard treatment with immunotherapy at the same time could potentially provide more long-lasting and effective treatments to increase survival."
Melanoma is the most deadly form of skin cancer with around 13,300 people diagnosed in the UK each year. Rates of the disease have increased more than fivefold since the mid 1970s.
Professor Richard Marais, director of the Cancer Research UK Manchester Institute and co-author of the study, said: "Melanoma is particularly difficult to treat as many patients develop resistance to standard treatment within a few years. This research provides a key insight into why this is the case.
"Drugs which block this 'survival signal' have already been developed and using these along with standard treatment may be a promising new approach for melanoma patients."INFORMATION:
Cancer Research UK joined forces with The Christie NHS Foundation Trust and The University of Manchester to form the Manchester Cancer Research Centre allowing doctors and scientists to work closely together to turn scientific advances into patient benefits sooner.
Smith et al. The immune-microenvironment confers resistance to MAP kinase pathway inhibitors through macrophage-derived TNFα (2014). Cancer Discovery.
Calming down immune cells could hold key to melanoma treatment
2014-09-25
ELSE PRESS RELEASES FROM THIS DATE:
Interactive website helps lower-income smokers to stop smoking
2014-09-25
People with lower incomes attempting to quit smoking are 36% more likely to succeed if they use a new interactive website called 'StopAdvisor' than if they use a static information website, finds a randomised controlled trial led by UCL researchers. The trial was funded by the National Prevention Research Initiative, a consortium of 16 UK health research funders.
A total of 4,613 smokers took part in the study, of whom 2,142 were classified into a 'lower income' group who had never worked, were long term unemployed or from routine or manual occupations (lower socioeconomic ...
Skirt size increase linked to 33 percent greater postmenopausal breast cancer risk
2014-09-25
Overall weight gain during adulthood is known to be a risk factor for breast cancer, but a thickening waist seems to be particularly harmful, indicating the importance of staving off a midriff bulge, the research shows.
The researchers base their findings on almost 93,000 women taking part in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) in England.
The women were all aged over 50, had gone through the menopause, and had no known breast cancer when they entered the study between 2005 and 2010.
At enrolment they provided detailed information on height ...
The Lancet Diabetes & Endocrinology: Working long hours linked to increased risk of type 2 diabetes
2014-09-25
People working for more than 55 hours per week doing manual work or other low socioeconomic status jobs have a 30% greater risk of developing type 2 diabetes, according to the largest study in this field so far, published in The Lancet Diabetes & Endocrinology.
Mika Kivimäki, Professor of Epidemiology at University College London, UK, and colleagues conducted a systematic review and meta-analysis of published studies and unpublished individual-level data examining the effects of long working hours on type 2 diabetes up to 30 April 2014.
Analysis of data from 4 published ...
Identification of genetic risk factors for stroke
2014-09-25
Stroke is one of the leading causes of death worldwide. While many lines of evidence suggest that stroke risk is heritable, only a small number of genes associated with stroke have been identified. A new study in the Journal of Clinical Investigation identifies two genes that underlie cerebral small-vessel disease (CSVD), a risk factor for stroke. Ordan Lehmann and colleagues at the University of Alberta analyzed genome-wide association data from individuals that received brain MRI scans as part of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) ...
Wound healing response promotes breast cancer metastasis in postpartum mice
2014-09-25
Within the first 5 years after the birth of a child, women are at an increased risk of developing metastatic breast cancer. Women diagnosed with postpartum breast cancer have a decreased disease free survival time compared to women that have never given birth. The aggressive tendency of postpartum breast cancer suggests that the post-birth breast environment promotes tumor metastasis. A new study in the Journal of Clinical Investigation, suggests that dying tumor cells in postpartum breast tissue promote metastatic disease. Rachel Cook and colleagues at Vanderbilt University ...
Memory slips may signal increased risk of dementia years later
2014-09-24
MINNEAPOLIS – New research suggests that people without dementia who begin reporting memory issues may be more likely to develop dementia later, even if they have no clinical signs of the disease. The study is published in the September 24, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.
"What's notable about our study is the time it took for this transition to dementia or clinical impairment to occur—about 12 years for dementia and nine years for clinical impairment—after the memory complaints began," said study author Richard ...
Think you have Alzheimer's? You just might be right, study says
2014-09-24
LEXINGTON, Ky. (Sept. 24, 2014) -- New research by scientists at the University of Kentucky's Sanders-Brown Center on Aging suggests that people who notice their memory is slipping may be on to something.
The research, led by Richard Kryscio, PhD, Chairman of the Department of of Biostatistics and Associate Director of the Alzheimer's Disease Center at the University of Kentucky, appears to confirm that self-reported memory complaints are strong predictors of clinical memory impairment later in life.
Kryscio and his group asked 531 people with an average age of 73 ...
Clinical trial examined treatment for complicated grief in older individuals
2014-09-24
Bottom Line: A treatment designed to help older individuals deal with complicated grief (CG) after the loss of a loved one appeared to be more effective than using a treatment designed for depression.
Authors: M. Katherine Shear, M.D., of the Columbia University School of Social Work, New York, and colleagues.
Background: About 9 percent of bereaved older women experience CG, a serious and debilitating mental health problem associated with functional impairment and increased suicidality. The symptoms can include prolonged grief, frequent thoughts and memories of the ...
Family-based therapies can treat anorexia in teens, Stanford/Packard study finds
2014-09-24
Two different family-based therapies are both effective at combating anorexia nervosa in teenagers, according to the largest study ever to compare two such treatments for the life-threatening eating disorder.
The findings, from a multisite study led by researchers at the Stanford University School of Medicine, add to a growing body of evidence supporting the value of parents' involvement in anorexia treatment.
The results, which will be published Sept. 24 in JAMA Psychiatry, follow prior Stanford research that found a family-based approach was twice as effective as ...
NIH study supports camels as primary source of MERS-CoV transmission
2014-09-24
National Institutes of Health (NIH) and Colorado State University (CSU) scientists have provided experimental evidence supporting dromedary camels as the primary reservoir, or carrier, of Middle East respiratory syndrome coronavirus (MERS-CoV). The study, designed by scientists from CSU and NIH's National Institute of Allergy and Infectious Diseases, involved three healthy camels exposed through the eyes, nose and throat to MERS-CoV isolated from a patient. Each camel developed a mild upper respiratory tract infection consistent with what scientists have observed throughout ...